{"id":"W4394999927","doi":"10.1007/s13555-024-01147-7","title":"Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60","year":2024,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Quality of life (healthcare); Psoriasis; Scalp; Dermatology; Physical therapy; Psoriatic arthritis; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00383771,0.0003577562,0.001526659,0.0004000404,0.000179126,0.0005980124,0.0002301031,0.0003051068,0.001693215],"category_scores_gemma":[0.002424048,0.0002173591,0.00205634,0.0004324664,0.0002053604,0.0004215016,0.000333172,0.0005161889,0.0001665136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002521288,"about_ca_system_score_gemma":0.0004700007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002968292,"about_ca_topic_score_gemma":0.0003487567,"domain_scores_codex":[0.9986513,0.0005459534,0.0001697376,0.0002678655,0.0002212408,0.0001439475],"domain_scores_gemma":[0.9984617,0.0005239838,0.0005185048,0.0001617925,0.0001608192,0.0001731889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4141864,0.003238889,0.365306,0.001739756,0.02101677,0.0001868285,0.0003833091,0.001899273,0.02095792,0.0001492897,0.001902531,0.1690331],"study_design_scores_gemma":[0.02323558,0.06345031,0.8935573,0.0001215072,0.01254338,0.000409946,0.0001316357,0.001524712,0.002364464,0.0001956861,0.002423376,0.00004210303],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938933,0.004186815,0.0004380401,0.00005867303,0.00002019829,0.0001232996,0.0006373837,0.00001897819,0.0006233992],"genre_scores_gemma":[0.9984731,0.0004576902,0.0002011972,0.00004995596,0.00002438312,0.00009488685,0.0005008975,0.000002543004,0.0001952124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00383771,"threshold_uncertainty_score":0.02029598,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02612450247803453,"score_gpt":0.2840526117640753,"score_spread":0.2579281092860407,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}